首页 | 本学科首页   官方微博 | 高级检索  
检索        

单一医生组原发性纵隔肿瘤外科治疗的长期随访
引用本文:付浩,陈克能,梁震,熊宏超,康晓征,戴亮,闫万璞,杨永波,杨合利,秦斌.单一医生组原发性纵隔肿瘤外科治疗的长期随访[J].中国肿瘤临床,2014,41(7):456-460.
作者姓名:付浩  陈克能  梁震  熊宏超  康晓征  戴亮  闫万璞  杨永波  杨合利  秦斌
作者单位:北京大学肿瘤医院胸外一科(北京市 100142)
基金项目:北京市卫生系统高层次卫生技术人才培养计划项目2009-2-17国家973计划项目2011CB504300教育部高等学校博士学科点专项科研基金项目20130001110108创新团队发展计划项目IRT13003
摘    要:   目的   总结单一医生组原发性纵隔肿瘤外科治疗的长期随访。   方法   数据来自北京大学肿瘤医院2000年1月至2014年1月的前瞻性数据库。分析纵隔肿瘤数据库中以根治切除为目的患者的远期生存。   结果   本组常见肿瘤依次为胸腺上皮肿瘤95例(50%),神经源性肿瘤26例(13.7%),纵隔生殖细胞肿瘤26例(13.7%)。全组患者行R0切除者179例(94.2%),R2切除者8例(4.2%),单纯探查者3例(1.6%),术后30d内死亡2例。胸腺上皮肿瘤1、3和5年生存率分别为95%、92.7%和85.7%。根据Masaoka-Koga分期,Ⅰ、Ⅱ、Ⅲ和Ⅳ期胸腺上皮肿瘤的5年生存率分别为100%、82.1%、90%和37.5%。多因素分析显示Masaoka-Koga分期是胸腺上皮肿瘤手术后独立预后因素。A+AB+B1型与B2+B3型胸腺瘤5年生存率分别为88.6%与76.9%,差异具有统计学意义(P < 0.05)。神经源性纵隔肿瘤多为良性,完整切除后均长期生存。   结论   纵隔肿瘤组织学复杂,根据其来源、性质、部位及大小来决定治疗。虽然本组患者生存良好,但单一医生组很难做到前瞻性,大样本研究。因此,对纵隔肿瘤尤其是胸腺上皮肿瘤亟需大样本,多中心合作的前瞻性研究,以找到合理的治疗方式。 

关 键 词:原发性纵隔肿瘤    胸腺上皮肿瘤    手术    生存
收稿时间:2014-01-10

Long-term follow-up of primary mediastinal tumor surgery by a surgeon team
Institution:Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department Ⅰof Thoracic Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China
Abstract:   Objective   Mediastinal tumors are tumors derived from different organs. Due to its rarity, few clinical consensuses on its diagnosis and treatments have been concluded. This paper aims to summarize the experiences of a single-surgeon team on the surgical treatment of primary medisatinal tumors.   Methods   Clinical data were collected from a prospective database between January 2000 and January 2014. The analyses were mainly focused on the long-term survival of 190 cases that underwent radical resectioning surgeries.   Results   The three most common mediastinal tumors are thymic epithelial tumors in 95 cases (50%), neurogenic tumors in 26 cases (13.7%), and mediastinal germ cell tumors in 26 cases (13.7%). Of the 190 patients, 179 patients achieved the R0 resection criterion (94.2%), 8 underwent R2 resectioning (4.2%) and 3 underwent only exploration (1.6%), with 2 cases of death in the 30 days after the surgery. The 1-, 3-, and 5-year survival rates of the thymic epithelial tumor patients were 95%, 92.7%, and 85.7%, respectively. According to the Masaoka-Koga staging, the 5-year survival rates of stage Ⅰ, Ⅱ, Ⅲ, and Ⅳ thymic epithelial tumors are 100%, 82.1%, 90%, and 37.5%, respectively. A multivariate analysis reveals that the Masaoka-Koga staging of thymic epithelial tumors is an independent prognostic factor (P < 0.05). According to pathological classification, the 5-year survival rates for A+AB+B1 versus B2+B3 type thymoma were 88.6% versus 76.9%, which is statistically significant (P < 0.05). Most of the neurogenic tumors are benign, all suffer R0 resectioning, and have long term survival.   Conclusion   Due to the complexity caused by its histology, the treatment of mediastinal tumors should be based on the origin, nature, location, and size of the tumors. Although the patients of the group have a favorable prognosis, it is difficult to draw conclusions from the studies because of its retrospective characteristics and small sample size. Therefore, to get better clinical evidence, a multi-center, large sample, and prospective clinical study should be performed. 
Keywords:
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号